Recall of Contaminated Propofol

Clinicians Advised to Halt Use of Propofol from Tainted Lots

The Centers for Disease Control and Prevention (CDC) has been investigating recent cases of febrile reactions among patients undergoing endoscopy in the United States. This investigation has revealed that all of the case-patients received the anesthetic propofol from 100 mL vials manufactured by Teva Pharmaceutical Industries. Testing done by the Food and Drug Administration (FDA) has found that two lots of this product that were in use in facilities reporting reactions were positive for elevated levels of endotoxin. The lots are 31305429B and 31305430B. Teva Pharmaceuticals is initiating a voluntary recall for these lots, and clinicians are advised to immediately stop using these lots of Teva Pharmaceuticals propofol. CDC, FDA and Teva Pharmaceutical Industries are continuing to investigate this issue.

THESE LOTS HAVE BEEN IDENTIFIED IN ARIZONA

Please contact your local health department or Claire Ogden (602) 364-3671 at ADHS if you have further questions or possible exposures to report.